Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
121 USD | -1.53% | +3.47% | -13.29% |
Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.29% | 19.57B | |
+7.76% | 220B | |
+6.58% | 185B | |
+10.90% | 133B | |
+26.68% | 107B | |
-0.57% | 62.91B | |
+15.76% | 53.34B | |
-1.89% | 47.71B | |
-1.65% | 40.29B | |
+10.71% | 39.57B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- Transcript : Illumina, Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-30-2022 09